A novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction and atypical

Thomas M Roston1, Wenting Guo2, Andrew D Krahn3

  • 1BC Inherited Arrhythmia Program, Vancouver, BC, Canada; Department of Medicine, University of British Columbia, Vancouver, BC, Canada; Department of Medicine, University of Alberta, Edmonton, AB, Canada.

Journal of Electrocardiology
|September 21, 2016
PubMed
Abstract

Insights

A novel RYR2 mutation (I4855M) causes a rare overlap syndrome of catecholaminergic polymorphic ventricular tachycardia (CPVT) and left ventricular non-compaction (LVNC). This loss-of-function mutation has a dominant-negative effect on RyR2, potentially leading to sudden death.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an ion channelopathy often caused by RYR2 mutations.
  • Left ventricular non-compaction (LVNC) is a genetic cardiomyopathy.
  • A rare overlap syndrome of LVNC and CPVT has been linked to RYR2 exon 3 deletion.

Purpose of the Study:

  • To characterize the phenotypic spectrum and molecular basis of a novel RYR2 mutation in a family with LVNC and CPVT.
  • To investigate the structural and functional impact of the identified RYR2 mutation.

Main Methods:

  • Clinical and genetic assessments of an affected family.
  • Homology modeling of the RYR2 pore-region to predict mutation impact.
  • In vitro Ca2+-release assays using HEK293 cells expressing the RYR2 mutant.

Main Results:

  • A multigenerational family presented with sudden death, atypical CPVT, and LVNC.
  • Genetic testing identified a novel RYR2 mutation (I4855M) in affected individuals.
  • In silico and functional studies indicated I4855M is a damaging loss-of-function mutation with a dominant-negative effect on wild-type RYR2.

Conclusions:

  • A novel RYR2 variant (I4855M) is associated with a potentially lethal overlap syndrome of LVNC and atypical CPVT.
  • The mutation acts as a loss-of-function, exerting a dominant-negative effect on RYR2.
  • This finding expands the understanding of RYR2-related cardiomyopathies and arrhythmias.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
611
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
748
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
724
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
705
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.5K
Dysrhythmias II: Classification of Tachyarrhythmias01:28

Dysrhythmias II: Classification of Tachyarrhythmias

Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
720